Chronic Kidney Disease

Dietary patterns may vary significantly in patients with different stages of chronic kidney disease, according to an investigation of food group intake among patients in a United Kingdom study.

Combined SGLT2 inhibitor and GLP-1 receptor agonist therapy could provide additional cardiovascular and renal benefits for adults with type 2 diabetes, according to data from a meta-analysis published in The Lancet Diabetes & Endocrinology.

Patients with chronic kidney disease or transplant should have ongoing access to telehealth to help manage care, according to results of a qualitative meta-analysis.

More than one in five adults in the U.S. with type 1 diabetes also have chronic kidney disease, according to findings from a brief report published in Diabetes Care.

In a study using U.S. Military Health System data, adoption of the 2021 Chronic Kidney Disease Epidemiology Collaboration equation that removes a race coefficient to determine eGFR may reclassify Black adults into more advanced CKD stages.

Patients with HIV who undergo immediate antiretroviral therapy may not experience significant differences in chronic kidney disease outcomes compared with patients who defer treatment.

Matrix metalloproteinase 2 may be associated with the progression of chronic kidney disease, especially in patients with low inflammation or with proteinuria, data show.

Shortly after graduating pharmacy school, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, was diagnosed with type 1 diabetes. Learning how to manage the disease while also going through pharmacy training was overwhelming, he said.

Eating a variety of natural fiber-rich foods and avoiding fiber with phosphate additives may help youth with chronic kidney disease to meet adequate dietary fiber intake.

ORLANDO — Semaglutide use was associated with significant reductions in worsening of kidney disease, cardiovascular events and all-cause death vs. placebo for adults with type 2 diabetes regardless of concomitant use of SGLT2 inhibitors.